Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

harout_semerjian

Ex-Novartis exec joins Ipsen as President, Head of Specialty Care

February 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen

Harout Semerjian has joined French pharma firm Ipsen as President, Head of Specialty Care International Region & Global Franchises, the …
Appointment
stergiopoulous

Ipsen names new Head of Global Medical Affairs

February 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen

French pharmaceutical firm Ipsen has announced its recruitment of Dr Sotirios Stergiopoulos as its Senior Vice President and Head of …
Appointment
cz_biohub-552_small

Chan Zuckerberg Biohub kick-starts hiring with 47 recruits

February 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CZ Biohub, Mark Zuckerberg, Zuckerberg

The Chan Zuckerberg Biohub, otherwise known as CZ Biohub, has announced its first in-take of recruits. The appointments are predominantly …
Appointment
debrecenhungary

More troubles for Teva as Israeli authorities open bribery investigation

February 8, 2017 Research and Development, Sales and Marketing Teva, bribery

Teva continues to struggle this week; after being hit with the bombshell that CEO Erez Vigodman, its third chief executive …
News
alexion

Alexion hits out at NICE ruling on Strensiq

February 8, 2017 Research and Development, Sales and Marketing Alexion, NICE, Strensiq

NICE has again drawn the ire of a company over its recommendation of its drug, this time round it’s Alexion …
News
mylan

Mylan pays $96.5 million to settle pay-for-delay case

February 7, 2017 Research and Development, Sales and Marketing Cephalon, Mylan, Teva, antitrust

Mylan has agreed to pay $96.5 million in order to settle an antitrust case. The case was related to the …
News
european_patent_office_munich-sign

New EPO regulations bad for biotech innovation, experts claim

February 7, 2017 Manufacturing and Production, Sales and Marketing EPO, IFPMA, SMEs, biotech

A recently-adopted initiative by the European Patent Office (EPO) to reduce patient examination times could lead to a stagnation of …
News
keytruda3-web

MSD aims to get the jump on BMS treating bladder cancer

February 6, 2017 Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, MSD, keytruda, opdivo

Bristol-Myers Squibb’s Opdivo was only just approved for second-line treatment of bladder cancer, but MSD has attempted to have its …
News
hugo_fry

Sanofi reinforces senior staff with two new execs

February 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Sanofi has reinforced its senior staff with a double-whammy of appointments; firstly, the French firm has announced that it is …
Appointment
ken_cunningham

Medherant appoints new Chairman

February 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medherant

Medherant has brought in Dr Ken Cunningham as Chair in a bid to strengthen the company as it moves into …
Appointment
johnson_and_johnson_jj

J&J breast implants “may have harmed thousands”, claims fresh lawsuit

February 6, 2017 Sales and Marketing J&J, JJ, Mentor Worldwide, breast implants

Mentor Worldwide, a unit of US pharma firm Johnson & Johnson, has been accused of selling defective breast implants and …
News

FDA clears Opdivo to treat most common form of bladder cancer

February 6, 2017 Sales and Marketing BMS, Bristol-Myers Squibb, MSD, bladder cancer, immunotherapy, keytruda, opdivo

Bristol-Myers Squibb’s Opdivo has acquired another indication – being given the go-ahead for treatment of patients with metastatic urothelial carcinoma. …
News
social_media

Socially vigilant: Does pharmacovigilance need secondary data & social media?

February 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, pharmacovigilance

As the world’s drug consumption continues to rise alongside advancements in the medical and pharmaceutical industries, so too do new …
Feature
dna_research

Link discovered between immune system genes and leukaemia

February 6, 2017 Research and Development, Sales and Marketing Bloodwise, ICR, leukaemia

Research coming out of The Institute of Cancer Research, and funded by charity Bloodwise, has found that people who inherit …
News
innate-pharma

Phase 2 failure for Innate Pharma leukaemia drug

February 6, 2017 Research and Development, Sales and Marketing Innate Pharma, leukaemia, lirilumab

Lirilumab, Innate Pharma’s acute myeloid leukaemia (AML) treatment, has failed to meet its primary end point in a recent Phase …
News
The Gateway to Local Adoption Series

Latest content

How will biomarker-led diagnostics reshape respiratory medicine?

October 11, 2026

Five Facts about COPD

October 11, 2026

“That gap between innovation and delivery was what stood out to me most”

October 11, 2026

Agentic commercial: how AI creates dialogue with HCPs and patients to help medicines reach them faster

October 11, 2026

Fortysomethings’ non-attendance at NHS Health Checks raises concerns, says study

October 11, 2026